CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
7 hedge funds and large institutions have $1.44M invested in Loncar China BioPharma ETF in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$1.3M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$45K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.42K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.3M | +$1.3M | +57,384 | New |
|
2
Morgan Stanley
New York
| $45K | – | – | – |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $45K | +$45K | +2,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $26K | +$9.42K | +416 | +57% |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $11K | +$11K | +500 | New |
|
6
Citigroup
New York
| $9K | – | – | – |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$2K | +100 | New |
|